In individuals with systemic lupus erythematosus (SLE) and Sjogren’s syndrome, increased TRIM21 expression downregulates BCL2, promotes extensive apoptosis, and compromises intracellular immunity. Here, BCL2 is linked to systemic lupus erythematosus.